Effectiveness of Scotland 's National Naloxone Programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison

Cited by (246)

Items 101–200 of 246

1. Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study
   Aase Grønlien Petterson, Desiree Eide · 2017 · Harm Reduction Journal
2. Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process
   Rosanna Smart, Sean Grant · 2021 · International Journal of Drug Policy
3. Costs of Opioid Overdose Education and Naloxone Distribution in New York City
   Czarina Navos Behrends, Sarah Gutkind, Emily R. Winkelstein, Monique Wright, Jennifer Dolatshahi, Alice E. Welch, Denise Paone, Hillary V. Kunins, Bruce R. Schackman · 2021 · Substance Abuse
4. Reducing opioid overdose in Kazakhstan: A randomized controlled trial of a couple-based integrated HIV/HCV and overdose prevention intervention “Renaissance”
   Louisa Gilbert, Timothy Hunt, Sholpan Primbetova, Assel Terlikbayeva, Mingway Chang, Elwin Wu, Tara McCrimmon, Nabila El‐Bassel · 2018 · International Journal of Drug Policy
5. Harm reduction programs and policy in Australia: barriers and enablers to effective implementation
   Daniel O’Keefe, Alison J. Ritter, Mark A Stoove, Chad Hughes, Paul Dietze · 2020 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
6. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies
   Carolina Barbosa, William N. Dowd, Gary A. Zarkin · 2020 · Value in Health
7. Methods for delivering the UK's multi‐centre prison‐based naloxone‐on‐release pilot randomised trial (N‐ALIVE): Europe's largest prison‐based randomised controlled trial
   Angela Mary Meade, Sheila Macdonald Bird, John Strang, Tracey Pepple, Laura Nichols, M Mascarenhas, Louise Choo, Mahesh Parmar · 2017 · Drug and Alcohol Review
8. Legal System Involvement and Opioid-Related Overdose Mortality in U.S. Department of Veterans Affairs Patients
   Andrea K. Finlay, Kristen Marie Palframan, Matthew A. Stimmel, John F. McCarthy · 2021 · American Journal of Preventive Medicine
9. Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping
   Fernanda S. Tonin, Filipa Alves da Costa, Fernando Fernández-Llimós · 2024 · Addiction Science & Clinical Practice
10. Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder
    Sarah Mary Bagley, Howard Cabral, Kelley Saia, Alyssa Brown, Christine A Lloyd-Travaglini, Alexander Yale Walley, Ruth Rose Jacobs · 2018 · Addiction Science & Clinical Practice
11. ‘I’m not going to leave someone to die’: carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiences
    Elizabeth M Speakman, Peter Hillen, Inga Heyman, Jennifer Murray, Nadine J Dougall, Elizabeth Aston, Andrew McAuley · 2023 · Harm Reduction Journal
12. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden
    Katja Troberg, Pernilla Isendahl, Marianne Alanko Blomé, Disa Dahlman, Anders Håkansson · 2020 · BMC Psychiatry
13. Characteristics of and Experience Among People Who Use Take-Home Naloxone in Skåne County, Sweden
    Katja Troberg, Pernilla Isendahl, Marianne Alanko Blomé, Disa Dahlman, Anders Håkansson · 2022 · Frontiers in Public Health
14. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel
    Roger Chou, Philip Todd Korthuis, Dennis W. McCarty, Phillip Oliver Coffin, Jessica Griffin, Cynthia Davis-O’Reilly, Sara Grusing, Mohamud Ramzan Daya · 2017
15. Time to look beyond ageing as a factor? Alternative explanations for the continuing rise in drug related deaths in Scotland
    Iain McPhee, Barry Sheridan, Steve O’Rawe · 2018 · Drugs and Alcohol Today
16. The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths
    Minji Sohn, Chris Delcher, Jeffery Talbert, Yue Cheng, Yong Xu, Emmanuel D. Jadhav, Patricia Rippetoe Freeman · 2022 · American Journal of Preventive Medicine
17. Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact
    John Strang · 2021 · European Addiction Research
18. Limited access to pharmacy-based naloxone in West Virginia: Results from a statewide purchase trial
    Robin A. Pollini, Jenny E. Ozga, Rebecca Joyce, Ziming Xuan, Alexander Yale Walley · 2021 · Drug and Alcohol Dependence
19. Best practice guidelines for viral hepatitis service delivery in prisons
    Yumi Sheehan, Akhil Garg, Julia Sheehan, Nonso Maduka, Frederick Lewis Altice, Filipa Alves da Costa, Sean Cox, Ahmed Mohamed Elsharkawy, Esam Y. Salah, Mark A Stoove et al. · 2025 · The Lancet Infectious Diseases
20. Harm Reduction in the Field: First Responders’ Perceptions of Opioid Overdose Interventions
    Callan Elswick Fockele, Tessa M. Frohe, Owen McBride, David L. Perlmutter, Brenda Y. Goh, Grover Williams, Courteney Wettemann, Nathan Holland, Brad Finegood, Thea Oliphant-Wells et al. · 2024 · Western Journal of Emergency Medicine
21. National consensus statement on opioid agonist treatment in custodial settings
    Jocelyn Chan, Jon Cook, Michael Curtis, Adrian John Dunlop, Ele Morrison, Suzanne Nielsen, Rebecca Winter, Thileepan Naren · 2025 · The Medical Journal of Australia
22. Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision
    Tomás Barry, Ján Klimas, Helen M. Tobin, Mairéad Egan, Gerard Bury · 2017 · British Journal of General Practice
23. Patient Perspectives of Barriers to Naloxone Obtainment and Use in a Primary Care, Underserved Setting: A Qualitative Study
    Jennifer Ko, Emily Chan, Shadi Doroudgar · 2021 · Substance Abuse
24. Harm reduction: a public health approach to prison drug use
    Linsey A. Belisle, Elia Del Carmen Solano-Patricio · 2021 · International Journal of Prisoner Health
25. Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies
    Grace Trull Marley, Izabela E. Annis, Bayla M. M. Ostrach, Kathleen L. Egan, Paul L. Delamater, Ronny A. Bell, Nabarun Dasgupta, Delesha M. Carpenter · 2024 · Journal of the American Pharmacists Association
26. Deaths in Custody and following Release
    Aaron D. Fox, Alia Moore, Ingrid A. Binswanger, Stuart Alistair Kinner · 2019 · Journal of Health and Human Services Administration
27. Injecting Alone is More Common among Men, Frequent Injectors and Polysubstance Users in a Sample of People Who Inject Drugs
    Linn Gjersing, Marte Kristin Helle · 2021 · Substance Use & Misuse
28. Intérêt de la mise à disposition de la naloxone auprès des usagers de drogues pour le traitement d’urgence de surdosage d’opioïdes
    Élisabeth Frauger, Farid Kheloufi, Quentin Boucherie, Emilie Monzon, Léonard Jupin, Nathalie Richard, Michel Mallaret, Joëlle Micallef · 2018 · Therapies
29. Impact of the Take Action Train-The-Trainer Model of Opioid Overdose Education with Naloxone Distribution– who Benefits?
    Chin Hwa Dahlem, Marci Scalera, Benrong Chen, Sean Esteban McCabe, Carol J. Boyd · 2019 · Substance Abuse
30. Experiences Administering Naloxone Among People in Different Social Roles: People Who Use Opioids and Family Members and Friends
    Adelya A. Urmanche, Alex Harocopos · 2022 · Journal of Drug Issues
31. Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey
    Caitlin O’Brien, Stephanie Klipp, Raagini Jawa, Jacqueline Deanna Wilson · 2024 · Harm Reduction Journal
32. ‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK
    Karen Duke, Julie D. Trebilcock · 2021 · International Journal of Drug Policy
33. Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia
    Michael Curtis, Anna Lee Wilkinson, Paul Dietze, Ashleigh Cara Stewart, Stuart Alistair Kinner, Reece David Cossar, Emily Nehme, Campbell Kynoch Aitken, Shelley Walker, Tony Gerard Butler et al. · 2023 · Emergency Medicine Journal
34. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial
    Barrot H. Lambdin, Ricky N. Bluthenthal, Bryan R. Garner, Lynn D. Wenger, Erica N. Browne, Terry Morris, Lee Ongais, Cariné E. Megerian, Alex H. Kral · 2024 · Implementation Science
35. Lessons learned in methods and analyses for pragmatic studies
    Patricia A. Eckardt, Ann C. Eckardt Erlanger · 2018 · Nursing Outlook
36. Understanding overdose incidents in Canadian federal custody
    Laura McKendy, Stephanie M. Biro, Magda Miron, Leslie Anne Keown · 2021 · International Journal of Drug Policy
37. Do Naloxone Access Laws Affect Perceived Risk of Heroin Use?: Evidence from National U.S. Data
    B. Kelly, Michael Vuolo · 2021 · Addiction
38. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study
    Tony Antoniou, Siyu Men, Mina Tadrous, Pamela Leece, Charlotte Munro, Tara Gomes · 2022 · Drug and Alcohol Dependence
39. Commentary on Irvine et al . (2019): Barriers to implementing a successful roadmap for preventing opioid‐related overdose deaths
    Joshua A. Barocas · 2019 · Addiction
40. The Donovan Memorial Lecture: ‘Fentanyl-Plus’: A New Era of Fentanyl Polydrug Combinations in the North American Overdose Crisis
    Daniel Ciccarone · 2025 · Journal of Medical Toxicology
41. Opioid-related emergency department visits and deaths after a harm-reduction intervention: a retrospective observational cohort time series analysis
    Matthew Yeung, Chel Hee Lee, Riley Hartmann, Eddy Lang · 2023 · CMAJ Open
42. Meeting the needs of prisoners with a drug or alcohol problem: No mean feat
    Neil McKeganey, Christopher Russell, Tiffany Hamilton-Barclay, Marina A. Barnard, Geoff Page, Charlie Lloyd, Sharon Grace, Lorna J. Templeton, Carole Bain · 2016 · Drugs Education Prevention and Policy
43. The hospital admission profile of people presenting to specialist addiction services with problematic use of alcohol or opioids: A national retrospective cohort study in England
    Emmert Roberts, Matthew H. Hotopf, John Strang, John Marsden, Martin White, Brian Eastwood, Colin Drummond · 2021 · The Lancet Regional Health - Europe
44. Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue
    Raúl Bejarano Romero, Jaime Arredondo Sanchez Lira, Said Slim, Alfonso Chavez, Lourdes Angulo, Anabel Salimian, Jorge J. Romero Vadilllo, David Goodman‐Meza · 2023 · The Lancet Regional Health - Americas
45. Saving Lives: The Veterans Health Administration (VHA) Rapid Naloxone Initiative
    Elizabeth M. Oliva, John Richardson, Michael Harvey, Pamela Bellino · 2021 · The Joint Commission Journal on Quality and Patient Safety
46. AI for the Common Good?! Pitfalls, challenges, and ethics pen-testing
    Berendt, Bettina · 2019 · Paladyn, Journal of Behavioral Robotics
47. Drug use among people in prison: A global review of epidemiology, harms and interventions
    Louis Favril, John Strang, Seena Fazel · 2025 · Addiction
48. Implementing an Opioid Risk Reduction Program in the Acute Comprehensive Inpatient Rehabilitation Setting
    Stephanie P. Van, Ada Lyn Yao, Teresa Tang, Margaret Kott, Amira Noles, Nicholas Dabai, Alexis M. Coslick, Solomon Rojhani, Lee Ann Sprankle, Erik H. Hoyer · 2019 · Archives of Physical Medicine and Rehabilitation
49. The effectiveness of changes to drug policy, regulation and legislation for reducing harms associated with opioids and supporting their medicinal use in Australia, Canada and the UK: A systematic review
    Ben O’Mara · 2020 · Evidence Base
50. The Overdose Response with Take Home Naloxone ( ORTHN ) project: Evaluation of health worker training, attitudes and perceptions
    Lauren Ann Monds, Maria Bravo, Llewellyn Mills, Annie Malcolm, Rosie Gilliver, William Wood, Mary Ellen Harrod, Phillip J. Read, Suzanne Nielsen, Paul Dietze et al. · 2022 · Drug and Alcohol Review
51. Community-led approaches to making naloxone available in public settings: Implementation experiences in the HEALing communities study
    Laura E. Starbird, Erica N. Onuoha, Grace J. Corry, Juanita Hotchkiss, Shoshana N. Benjamin, Timothy Hunt, Bruce R. Schackman, Nabila El‐Bassel · 2024 · International Journal of Drug Policy
52. Optimising opioid substitution therapy in the prison environment
    Farrukh Alam, Nat M. J. Wright, Paul Roberts, Sunny Dhadley, Joanne Townley, Russell Webster · 2019 · International Journal of Prisoner Health
53. Recovery support specialists inside the jail: a program description of treatment engagement for opioid use disorder
    Matthew P. Martin, Megan A. Phillips, Mary Saxon, Kailey Love, Laurie Cessna, Deborah L. Woodard, Mary Page, Kenneth H. Curry, Alyssa Paone, Bobbie Pennington-Stallcup et al. · 2021 · International Journal of Prisoner Health
54. Treating Opioid Use Disorder in Correctional Settings
    Rachel Simon, Josiah D. Rich, Sarah E. Wakeman · 2021 · Springer eBooks
55. Emotional Reactions of Trained Overdose Responders who use Opioids following Intervention in an Overdose Event
    Laura Brandt, Aimee N. C. Campbell, Jermaine D. Jones, Suky Martinez, Joanne Neale, Stephen Parkin, Caral Brown, John Strang, Sandra D. Comer · 2021 · Substance Abuse
56. Naloxone in Correctional Facilities for the Prevention of Opioid Overdose Deaths
    2021 · Journal of Correctional Health Care
57. A Qualitative Analysis of Emergency Medical Services Personnel Experiences and Perception Responding to Drug Overdoses in the US during the COVID-19 Pandemic
    Nae Yeon Won, Joseph J. Palamar, Stephen A. Mike, Nicole D. Fitzgerald, Linda Bauer Cottler · 2023 · Journal of Health Research
58. Preliminary effectiveness of online opioid overdose and naloxone administration training and impact of naloxone possession on opioid use
    Michelle L. Sisson, Andrés Azuero, Keith R. Chichester, Matthew J. Carpenter, Michael S. Businelle, Richard Charles Shelton, Karen L. Cropsey · 2023 · Drug and Alcohol Dependence
59. Fatal and non-fatal overdose after narcology hospital discharge among Russians living with HIV/AIDS who inject drugs
    Alexander Yale Walley, Debbie M. Cheng, Emily Kate Quinn, Elena A. Blokhina, Natalia Gnatienko, Christine E. Chaisson, Evgeny M. Krupitsky, Phillip Oliver Coffin, Jeffrey H. Samet · 2016 · International Journal of Drug Policy
60. Overdose Education and Naloxone Distribution: An Evidence-Based Practice That Warrants Course Correcting
    Maya Doe-Simkins, Eliza Wheeler · 2024 · American Journal of Public Health
61. Value for money in reducing opioid-related deaths
    Wayne Hall, John Strang · 2017 · The Lancet Public Health
62. Take-Home Naloxon: Ein Baustein der Drogennotfallprophylaxe auch in Deutschland
    Simon Fleißner, Heino Stöver, Dirk Schäffer · 2023 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
63. External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial
    Sheila Macdonald Bird, John Strang, Deborah Ashby, John Podmore, Roy Robertson, Sarah Welch, Angela Mary Meade, Mahesh Parmar · 2017 · Contemporary Clinical Trials Communications
64. The use of public health infrastructure probably the best strategy for national and large‐scale naloxone distribution programmes
    Desiree Eide, Thomas Clausen · 2016 · Addiction
65. Opioid overdoses and overdose prevention: The establishment of take-home naloxone in Norway
    Desiree Eide · 2017 · NORA - Norwegian Open Research Archives
66. Older-age opioid-related deaths in the UK
    Sheila Macdonald Bird, Roy Robertson · 2020 · The Lancet
67. Overdose education and naloxone distribution in jails: Examining the impact of the Communities That HEAL intervention in 4 states
    Timothy Hunt, Carrie B. Oser, Peter D. Friedmann, Nicole A. Mack, Peter Balvanz, Bridget Freisthler, Redonna K. Chandler, Karli R. Hochstatter, Daniel R. Harris, LaShawn Glasgow et al. · 2025 · Health & Justice
68. Supporting people responding to overdoses
    Charles Marks, Karla D. Wagner · 2022 · The Lancet Public Health
69. Opioid‐related deaths and their counterpart by occurrence era, age group and coimplicated drugs: Scotland vs. England and Wales
    Sheila Macdonald Bird · 2023 · British Journal of Clinical Pharmacology
70. Take-home naloxone in opioid dependency
    Simon Fleißner, Heino Stöver, Dirk Schäffer, Heike Wodarz-von Essen, Daniel Deimel, Norbert Wodarz · 2025 · Deutsches Ärzteblatt international
71. Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016–2020
    Mathieu Chappuy, Lotfi Fezzani, Delphine Ragonnet, Aurélie Berger-Vergiat, Nathalie Duvernay, Philippe Lack, Benjamin Rolland · 2022 · Therapies
72. National increase in the community supply of take‐home naloxone associated with a mass media campaign in Scotland: a segmented time series analysis
    Kirsten M. A. Trayner, A Yeung, Harry R. Sumnall, Martin E. Anderson, Megan Glancy, Amanda Marie Atkinson, Michael S. Smith, Andrew McAuley · 2023 · International Journal of Drug Policy
73. Suchtmedizin unter kustodialen Bedingungen am Beispiel des Berliner Justizvollzuges
    Julia Krebs, Norbert Konrad, Annette Opitz‐Welke · 2020 · Forensische Psychiatrie Psychologie Kriminologie
74. Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas
    Patricia A. Eckardt, Donald E. Bailey, Holli A. DeVon, Cynthia M. Dougherty, Pamela Ginex, Cheryl A. Krause‐Parello, Rita H. Pickler, Therese S. Richmond, Eleanor Rivera, Carol F. Roye et al. · 2020 · Nursing Outlook
75. Effectiveness of Scotland's national naloxone programme: response to letter to editor
    Sheila Macdonald Bird, Andrew McAuley, Samantha Perry, Carole Hunter · 2016 · Addiction
76. Take‐home naloxone in Australia and beyond
    Anna Olsen, Robyn Dwyer, Simon R Lenton · 2018 · Drug and Alcohol Review
77. The implementation of take-home naloxone: Lessons learned from a 3-year take-home naloxone project in Germany
    Simon Fleißner, Larissa Steimle, Dirk Schäffer, Bernd Werse, Daniel Deimel, Maria Kuban, Heino Stöver · 2025 · Harm Reduction Journal
78. Could Flumazenil Be Used Pre‐hospital by Intramuscular Injection for Coma due to Mixed Drug Overdose Not Responding to Naloxone?: A Systematic Review of the Evidence
    Ilinca Maria Farcaș, Lisa Schölin, Michael Eddleston · 2025 · Basic & Clinical Pharmacology & Toxicology
79. Broad-scale overdose education and naloxone distribution– 5-year follow-up of a regional program in Skåne County, Sweden
    Katja Troberg, Pernilla Isendahl, Disa Dahlman, Anders Håkansson · 2025 · Harm Reduction Journal
80. An impact evaluation of the Scottish take-home naloxone programme
    Tobias Joseph Adams, Joseph Tay Wee Teck, Alexander Baldacchino, Patrice Forget · 2025 · Health Policy and Technology
81. Current Opioid Access, Use, and Problems in Central and Western European Jurisdictions
    Daniel Fuster, Roberto Muga, Olivier Simon, Nicolas Bertholet · 2018 · Current Addiction Reports
82. Changes in overdose knowledge and attitudes in an incarcerated sample of people living with HIV
    Megan K. Reed, Anne Siegler, Loni Philip Tabb, Florence Marie Momplaisir, Dorsche Krevitz, Stephen E. Lankenau · 2021 · International Journal of Prisoner Health
83. Non‐fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study
    Michael Curtis, Paul Dietze, Rebecca Winter, Kasun Rathnayake, Karen L. Smith, Mark A Stoove · 2022 · The Medical Journal of Australia
84. Assessing the reach and engagement with the ‘ How To Save A Life ’ mass media campaign on drug-related death prevention in Scotland
    M. Anderson, Amanda Marie Atkinson, Andrew McAuley, Harry R. Sumnall, Megan Glancy, Harriet Bloomfield, Kirsten M. A. Trayner · 2023 · Drugs Education Prevention and Policy
85. An economic evaluation of community pharmacy–dispensed naloxone in Canada
    Ashley Cid, Nikita Mahajan, William W. L. Wong, Michael A. Beazely, Kelly Grindrod · 2024 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
86. “Before medically advised” hospital discharge and the risk of subsequent drug overdose: A case‐crossover analysis
    John A. Staples, Xiao Hu, Mayesha Khan, Daniel Daly‐Grafstein, Hiten Naik, Benjamin M. Kaasa, Jeffrey Reynold Brubacher, Trudy Nasmith, Jennifer R. Lyden, Jessica Moe et al. · 2024 · Journal of Hospital Medicine
87. The Significant Impact of Narcan Reversals on Overdose Mortality in Peoria County, IL
    Mohammad Mousbah Al-Tabbaa, Ehssan Bdiwi, Kathryn Endress, Khaled Altarras · 2022 · Cureus
88. The opioid problem in primary care
    Roy Robertson · 2020 · British Journal of General Practice
89. Description of implementing a mail-based overdose education and naloxone distribution program in community supervision settings during COVID-19
    Carrie B. Oser, Margaret McGladrey, Douglas R. Oyler, Hannah K. Knudsen, SHARON L. WALSH, Susannah Stitzer, Michael Goetz, Marisa D. Booty, Erica Hargis, Sarah Johnson et al. · 2024 · Journal of Substance Use and Addiction Treatment
90. Illicit drug supply, naloxone availability, and overdose mortality in the fentanyl era: a systematic review
    Mehrdad Khezri, Julie Holm, Alex Dahlen, Christian E. Johnson, Kofi Agyabeng, Frederick Lei, J R Colón Pagán, Cheryl G. Healton, Tilda Farhat · 2026 · Health Affairs Scholar
91. Reducing Overdose Through Policy Interventions: ASTHO's Recommendations for State and Territorial Health Officials and Agencies
    Victoria Pless, JoAnne McClure, Maggie Davis, Jennifer Farfalla, Yaryna Onufrey, Kayley Humm, Richa Ranade, Mary Terzian · 2023 · Journal of Public Health Management and Practice
92. U.S. Jails and fatal drug overdoses: patterns, predictors and the role of rehabilitative contexts
    Victor St. John, Tasha Perdue, Jason Szkola, Mijin Kim, Katharine McGrath, Noa Glover, Josh Sugino · 2025 · Health & Justice
93. Take-home naloxone is a global issue, in practice and in research: A response to Heavey et al.
    Andrew McAuley, Sheila Macdonald Bird · 2018 · International Journal of Drug Policy
94. Substance-Related and Addictive Disorders
    Thomas R. Kosten, Thomas F. Newton, Richard De La Garza, Colin N. Haile · 2014 · American Psychiatric Association Publishing eBooks
95. Study‐design in pandemics: From surveillance and performance‐evaluation to licensing and pharmacovigilance
    Sheila Macdonald Bird · 2022 · Pharmaceutical Statistics
96. Effects of Online Naloxone Training for Laypersons: An Extended-Baseline Assessment
    Wasantha Parakrama Jayawardene, Hye Jeong Choi, Chesmi Kumbalatara, Jacob Ketuma, Justin Tyler McDaniel, Michael L. Hecht · 2024 · Substance Use & Misuse
97. Naloxone nasal spray (Nyxoid®) in opioid overdose: a profile of its use in the EU
    Kate McKeage, Katherine Ann Lyseng-Williamson · 2018 · Drugs & Therapy Perspectives
98. Increasing Naloxone Access and Prescribing for Patients on High-Dose Opioids From a Managed Care Pharmacy Health Plan Perspective
    Jodi P. Hansgen, Megan Robertson, Ellen Verzino, Lindsay M. Manning · 2024 · Journal of Pharmacy Practice
99. What Are Community Supervision Officers’ Knowledge and Views of Naloxone? An Exploratory Study
    Linsey A. Belisle, Tereza Trejbalová, Kimberly R. Kras · 2024 · Criminal Justice and Behavior
100. Overdose response centering inequity and diversity study: a protocol for assessing the population-level and equity impact of the emergency medical services system changes using critical race theory
     Ohshue S. Gatanaga, Nicholas Cotta, Kimiam Waters, Alden Gu, Omeid Heidari, Tessa M. Frohe, Courteney Wettemann, Andre Morris, Esther Rourke, India J. Ornelas et al. · 2025 · Frontiers in Public Health